Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule
Prof Peter Taylor opened the symposium focussed on optimisation of treatment for rheumatoid arthritis (RA) at each stage of the patient’s journey. Prof Ronald van Vollenhoven reviewed the evidence for first- line biologics in the ‘exceptional patient’ and explored which patients may be suitable for...
Main Authors: | Peter Taylor, Ronald van Vollenhoven, Daniel Aletaha |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2016-07-01
|
Series: | European Medical Journal Rheumatology |
Subjects: | |
Online Access: | http://emjreviews.com/wp-content/uploads/Optimising-Patient-Outcomes-Throughout-the-Rheumatoid-Arthritis-Patient-Journey-The-Exception-the-Standard-and-the-Rule.pdf |
Similar Items
-
Precision Medicine: Maximising Treatment Benefit for Rheumatoid Arthritis Patients
by: Ernest Choy, et al.
Published: (2016-07-01) -
Think Rheumatoid Arthritis: Causes, Consequences, and Management
by: Josef Smolen, et al.
Published: (2016-07-01) -
Unravelling the Mystery Between Structure and Sustained Clinical Outcomes
by: Edward Keystone, et al.
Published: (2016-07-01) -
Osteoarthritis: The Challenge of Establishing a Personalised Treatment
by: Johanne Martel-Pelletier, et al.
Published: (2014-06-01) -
IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis
by: Atul Deodhar, et al.
Published: (2015-07-01)